-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Coya Therapeutics, Inc. quarterly and annual Operating Income (Loss) history and change rate from 2021 to Q3 2025.
- Coya Therapeutics, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was $-2,432,897, a 45.3% increase year-over-year.
- Coya Therapeutics, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $-20,604,632, a 81.5% decline year-over-year.
- Coya Therapeutics, Inc. annual Operating Income (Loss) for 2024 was $-17,249,711, a 118% decline from 2023.
- Coya Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $-7,903,349, a 19.5% increase from 2022.
- Coya Therapeutics, Inc. annual Operating Income (Loss) for 2022 was $-9,811,939, a 101% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)